Journal of Nanobiotechnology · 2024 · 61 citations · 138 references
Life SciencesBiochemistryBiotechnologyDrug DeliveryEnzymologyNanobiotechnologyAntioxidant DefenseNanomedicineOxidative Damage To BiomoleculesOxidative StressEnzymesMetabolic Disorder TherapyReactive Oxygen Species GenerationSafety AnalysisTherapeutic Mechanisms
Nanozyme, characterized by outstanding and inherent enzyme-mimicking properties, have emerged as highly promising alternatives to natural enzymes owning to their exceptional attributes such as regulation of oxidative stress, convenient storage, adjustable catalytic activities, remarkable stability, and effortless scalability for large-scale production. Given the potent regulatory function of nanozymes on oxidative stress and coupled with the fact that reactive oxygen species (ROS) play a vital role in the occurrence and exacerbation of metabolic diseases, nanozyme offer a unique perspective for therapy through multifunctional activities, achieving essential results in the treatment of metabolic diseases by directly scavenging excess ROS or regulating pathologically related molecules. The rational design strategies, nanozyme-enabled therapeutic mechanisms at the cellular level, and the therapies of nanozyme for several typical metabolic diseases and underlying mechanisms are discussed, mainly including obesity, diabetes, cardiovascular disease, diabetic wound healing, and others. Finally, the pharmacokinetics, safety analysis, challenges, and outlooks for the application of nanozyme are also presented. This review will provide some instructive perspectives on nanozyme and promote the development of enzyme-mimicking strategies in metabolic disease therapy.
138
Pouya Saeedi, Inga Petersohn, Belma Malanda et al. · Diabetes Research and Clinical Practice · 2019 · 10.5K citations
Intrinsic peroxidase-like activity of ferromagnetic nanoparticles
Lizeng Gao, Jie Zhuang, Leng Nie et al. · Nature Nanotechnology · 2007 · 7.3K citations
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
Philip R. Schauer, Deepak L. Bhatt, John P. Kirwan et al. · New England Journal of Medicine · 2017 · 2.9K citations · Full text
Medicine, Endocrinology, Surgery +16
Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy
Tian Tian, Huixin Zhang, Chunpeng He et al. · Biomaterials · 2017 · 1.1K citations